Simcere Pharmaceutical Group · Nanjing, Jiangsu China ·(NYSE: SCR)

With all simcerity, this pharmaceutical company wishes you well. Simcere Pharmaceutical Group manufactures and sells branded generic drugs in China. Its core portfolio consists of some 40 products, including an anti-cancer drug, a line of potassium antibiotics, an anti-diarrhea medicine, an anti-inflammatory pain reliever, and an anti-stroke medication. Additionally, Simcere has a number of products under development. Launched in 1995, the company sells its pharmaceuticals to regional distributors who sell them to local distributors, hospitals, and retail pharmacies throughout China. To read the full description, subscribe now.